The world health Organization (WHO) announced Saturday that it would put an end to its study on the hydroxychloroquine as a possible treatment for the COVID-19.
The WHO has stated, by way of a press release, that it has taken this decision following the recommendations of the international steering committee on research on the virus. The scientists will suspend also the research on the combination of lopinavir and ritonavir, which is a recognized treatment against HIV.
The research group announced its findings on the subject in the 1st and 2nd of July last, at a summit of the WHO on the COVID-19.
“The interim results show that hydroxychloroquine, and lopinavir/ritonavir does not result in little or no reduction in the mortality of patients hospitalized for the COVID-19, compared to a standard treatment,” said the organization.
Conversely, the use of these products has not resulted in additional mortality. The results of this research do not affect the studies of patients not admitted to hospital or treatment prevention, said the WHO.
Treatment with chloroquine and hydroxychloroquine have done much talking during the last month, with some touting its merits, while others have pointed out the risks of its use. In the month of April, Health Canada had warned the population in this sense.
The two drugs can cause serious side effects, such as heart rhythm disorders. No drug to prevent the COVID-19 has since been marketed, even if Canada has indicated to conduct clinical trials on these two products.
In France, the popular microbiologist Didier Raoult is a great advocate of the use of chloroquine and hydroxychloroquine. His research has, however, been highly criticized by the scientific community. For his part, Donald Trump has described the drug as “a gift from heaven”.
On social media, the terms “chloroquine” and “hydroxychloroquine” have become more popular than ever and often appear in multiple conspiracy theories circulating on the web.
Used usually these medicines as a treatment for arthritis and its use is highly supervised by the hospitals.